MORF4L2 induces immunosuppressive microenvironment and immunotherapy resistance through GRHL2/MORF4L2/H4K12Ac/CSF1 axis in triple-negative breast cancer (vol 13, 6, 2025)

被引：0
|
作者：
Sui, Xin-Yi [1 ,2 ]
Cao, Shuo-Wen [1 ,2 ]
Song, Xiao-Qing [1 ,2 ]
Liu, Xi-Yu [1 ,2 ]
Chen, Chao [1 ,2 ]
Yan, Qingya [3 ]
Wang, Zhi-Qing [1 ,2 ]
Zhang, Wen-Juan [1 ,2 ]
Ma, Lin-Xiaoxi [1 ,2 ]
Jin, Xi [1 ,2 ]
Ma, Ding [1 ,2 ]
Xiao, Yi [1 ,2 ]
Wu, Song-Yang [1 ,2 ]
Xu, Ying [1 ,2 ]
Shao, Zhi-Ming [1 ,2 ]
Fan, Lei [1 ,2 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Key Lab Breast Canc Shanghai, Shanghai, Peoples R China
[3] Xinxiang Med Univ, Sch Basic Med Sci, Xinxiang, Peoples R China
来源：
BIOMARKER RESEARCH | 2025年 / 13卷 / 01期
关键词：
D O I：
10.1186/s40364-025-00743-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 6 条
  • [1] MORF4L2 induces immunosuppressive microenvironment and immunotherapy resistance through GRHL2/MORF4L2/H4K12Ac/CSF1 axis in triple-negative breast cancer
    Sui, Xin-Yi
    Cao, Shuo-Wen
    Song, Xiao-Qing
    Liu, Xi-Yu
    Chen, Chao
    Yan, Qingya
    Wang, Zhi-Qing
    Zhang, Wen-Juan
    Ma, Lin-Xiaoxi
    Jin, Xi
    Ma, Ding
    Xiao, Yi
    Wu, Song-Yang
    Xu, Ying
    Shao, Zhi-Ming
    Fan, Lei
    BIOMARKER RESEARCH, 2025, 13 (01)
  • [2] CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer
    Shrestha, Mariusz
    Wang, Dong-Yu
    Ben-David, Yaacov
    Zacksenhaus, Eldad
    ONCOGENESIS, 2023, 12 (01)
  • [3] CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer
    Mariusz Shrestha
    Dong-Yu Wang
    Yaacov Ben-David
    Eldad Zacksenhaus
    Oncogenesis, 12
  • [4] ASH2L plays a role in triple-negative breast cancer cells through the control of histone H3 lysine 4 methylation
    Ishimura, Akihiko
    Terashima, Minoru
    Takino, Takahisa
    Suzuki, Takeshi
    CANCER SCIENCE, 2024, 115 : 226 - 226
  • [5] ASH2L, a COMPASS core subunit, is involved in the cell invasion and migration of triple-negative breast cancer cells through the epigenetic control of histone H3 lysine 4 methylation
    Batbayar, Gerelsuren
    Ishimura, Akihiko
    Lyu, Hanbing
    Wanna-udom, Sasithorn
    Meguro-Horike, Makiko
    Terashima, Minoru
    Horike, Shin-ichi
    Takino, Takahisa
    Suzuki, Takeshi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 669 : 19 - 29
  • [6] KMT2D-mediated H3K4me1 recruits YBX1 to facilitate triple-negative breast cancer progression through epigenetic activation of c-Myc
    Yao, Bing
    Xing, Mengying
    Zeng, Xiangwei
    Zhang, Ming
    Zheng, Que
    Wang, Zhi
    Peng, Bo
    Qu, Shuang
    Li, Lingyun
    Jin, Yucui
    Li, Haitao
    Yuan, Hongyan
    Zhao, Quan
    Ma, Changyan
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (07):
1